CroiValve

Veteran structural heart executive to lead the company through its next phase of clinical and commercial growth Dublin, Ireland, 28th July 2026 - CroíValve, a clinical-stage medical device company developing the DUO transcatheter tricuspid coaptation valv

CroíValve announced that it has closed $20 million in Series B expansion financing, along with $7 million in European Innovation Council and DTIF grant financing. The additional capital brings CroíValve's Series B total to $36 million and $43 million, inc

Professor Grygier, Poznan University of Medical Sciences Team and the CroíValve Team following DUO Adapt cases Dublin, Ireland, June 23, 2026 - CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for t

Dublin, Ireland, July 1, 2025 - CroíValve, a pioneering medical device company innovating a better way to help more patients suffering from Tricuspid Regurgitation (TR), were awarded funding from Horizon Europe's European Innovation Council (EIC) Accelera

CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced the first patient treated with the DUO System as part of the TANDEM II Early Fea